STOCK TITAN

RBC Bearings (RBC) CFO receives stock grant and new option award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RBC Bearings Vice President and CFO Robert M. Sullivan reported routine equity compensation. He received a grant of 1,233 shares of Common Stock at $0.00 per share, bringing his direct holdings to 13,420 shares. He was also granted an option on 2,506 shares of Common Stock at an exercise price of $565.22 per share, exercisable in five annual installments beginning on May 19, 2027 and expiring on May 19, 2033. The filing also lists several existing option awards with various exercise prices and expiration dates, many of which are already exercisable, providing additional long-term exposure to RBC Bearings stock.

Positive

  • None.

Negative

  • None.
Insider Sullivan Robert M
Role Vice President and CFO
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 2,506 $0.00 --
Grant/Award Common Stock 1,233 $0.00 --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 2,506 shares (Direct, null); Common Stock — 13,420 shares (Direct, null)
Footnotes (1)
  1. Includes 7,593 shares of restricted stock, which vest according to the following schedule - 200 shares that vest on 6/3/2026; 800 shares 1/2 of which vest on 6/3/2026 and 1/2 vest on 6/3/2027; 1,800 shares 1/3 of which vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028; 800 shares 1/4 of which vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029; 960 shares 1/4 of which vest on 11/5/2026, 1/4 vest on 11/5/2027, 1/4 vest on 11/5/2028 and 1/4 vest on 11/5/2029; 1,800 shares 1/5 or which vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030; and 1,233 shares 1/5 or which vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031. All these options to purchase Common Stock are exerciseable except for 1,000 options that vest on 6/3/2026. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2026 and 1/2 vest on 6/3/2027. All these options to purchase Common Stock are exerciseable except for 3,000 options that are subject to the following vesting schedule - 1/3 vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/4 vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029. All these options to purchase Common Stock are exerciseable except for 1,200 options that vest according to the following schedule: 1/4 vest on 11/5/2026; 1/4 vest on 11/5/2027; 1/4 vest on 11/5/2028 and 1/4 vest on 11/5/2029. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030.
Common stock grant 1,233 shares Grant of Common Stock at $0.00 per share on May 19, 2026
Shares owned after grant 13,420 shares Total direct Common Stock holdings following the reported grant
New option grant size 2,506 shares Underlying Common Stock for new option award granted May 19, 2026
New option exercise price $565.22 per share Exercise price for 2,506-share option expiring May 19, 2033
Existing option at $199.51 5,000 underlying shares Option to purchase Common Stock at $199.51 expiring June 1, 2030
Restricted stock holdings 7,593 shares Restricted stock vesting between June 3, 2026 and May 19, 2031
Lowest option exercise price $137.44 per share Option on 2,000 underlying shares expiring June 2, 2027
restricted stock financial
"Includes 7,593 shares of restricted stock, which vest according to the following schedule"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting schedule financial
"These options to purchase Common Stock are subject to the following vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
exercise price financial
"conversion_or_exercise_price": "565.2200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Option to Purchase Common Stock financial
"security_title": "Option to Purchase Common Stock""
expiration date financial
"expiration_date": "2033-05-19T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sullivan Robert M

(Last)(First)(Middle)
180 WINDMILL HILL

(Street)
WETHERSFIELD CONNECTICUT 06109

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ RBC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A1,233A$013,420(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$565.2205/19/2026A2,50605/19/2027(2)05/19/2033Common Stock2,506$02,506D
Option to Purchase Common Stock$137.4406/02/202506/02/2027Common Stock2,0002,000D
Option to Purchase Common Stock$199.1606/03/2022(3)06/03/2028Common Stock5,0005,000D
Option to Purchase Common Stock$199.106/03/2023(4)06/03/2029Common Stock4,0004,000D
Option to Purchase Common Stock$199.5106/01/2024(5)06/01/2030Common Stock5,0005,000D
Option to Purchase Common Stock$292.8505/23/2025(6)05/23/2031Common Stock2,0002,000D
Option to Purchase Common Stock$287.8511/05/2025(7)11/05/2031Common Stock1,5001,500D
Option to Purchase Common Stock$364.9605/28/2026(8)05/28/2032Common Stock3,5003,500D
Explanation of Responses:
1. Includes 7,593 shares of restricted stock, which vest according to the following schedule - 200 shares that vest on 6/3/2026; 800 shares 1/2 of which vest on 6/3/2026 and 1/2 vest on 6/3/2027; 1,800 shares 1/3 of which vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028; 800 shares 1/4 of which vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029; 960 shares 1/4 of which vest on 11/5/2026, 1/4 vest on 11/5/2027, 1/4 vest on 11/5/2028 and 1/4 vest on 11/5/2029; 1,800 shares 1/5 or which vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030; and 1,233 shares 1/5 or which vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
2. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
3. All these options to purchase Common Stock are exerciseable except for 1,000 options that vest on 6/3/2026.
4. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2026 and 1/2 vest on 6/3/2027.
5. All these options to purchase Common Stock are exerciseable except for 3,000 options that are subject to the following vesting schedule - 1/3 vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028.
6. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/4 vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029.
7. All these options to purchase Common Stock are exerciseable except for 1,200 options that vest according to the following schedule: 1/4 vest on 11/5/2026; 1/4 vest on 11/5/2027; 1/4 vest on 11/5/2028 and 1/4 vest on 11/5/2029.
8. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030.
Remarks:
/s/John J. Feeney/attorney in fact05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RBC (RBC) CFO Robert M. Sullivan report in this Form 4?

RBC Bearings CFO Robert M. Sullivan reported receiving equity compensation, including 1,233 shares of Common Stock and a new stock option. The filing also details his existing option awards and updated total direct share ownership after these grants.

How many RBC (RBC) shares does the CFO hold after these transactions?

After the reported grant, Robert M. Sullivan directly holds 13,420 shares of RBC Bearings Common Stock. This figure includes restricted stock that will vest over time according to detailed schedules described in the accompanying footnotes.

What are the details of the new stock option granted to the RBC CFO?

The new award is an option to purchase 2,506 shares of RBC Bearings Common Stock at an exercise price of $565.22 per share. It vests in five equal annual installments starting May 19, 2027 and expires on May 19, 2033.

Did the RBC (RBC) CFO buy or sell shares on the open market in this filing?

No open-market purchases or sales are shown in this Form 4. The filing reports equity compensation grants and existing option positions, not discretionary market trades by the CFO or related entities.

What existing stock options does the RBC CFO have according to this Form 4?

The Form 4 lists several existing options to purchase RBC Bearings Common Stock, with exercise prices ranging from $137.44 to $364.96 and expiration dates between 2027 and 2032. Many of these options are already exercisable, with some portions still subject to vesting schedules.

How much restricted stock does the RBC (RBC) CFO have and how does it vest?

Footnotes state that Robert M. Sullivan holds 7,593 shares of restricted stock. These shares vest in tranches between June 3, 2026 and May 19, 2031, with varying schedules that include annual vesting over two to five years depending on each grant.